GSK: Delaware Supreme Court agrees appeal over Zantac cancer case claim
Pharmaceutical giant GlaxoSmithKline (GSK) and rival drug manufacturers, including Sanofi, Pfizer and Boehringer Ingelheim, have won the right to an appeal hearing by the Delaware Supreme Court, regarding the now-discontinued antacid Zantac amid claims that an ingredient in it may cause cancer. There are now more than 70,000 lawsuits regarding the drug.


